We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Data Provide Clues into Why Some Lung Tumors Are Undetected by X-Ray

By HospiMedica International staff writers
Posted on 12 Sep 2012
New research has revealed why some lung tumors are undetected by X-ray and helped to identify the type of individuals who may be at risk of this sort of lung cancer. More...


The study’s findings were presented on September 3, 2012, at the European Respiratory Society’s annual Congress in Vienna (Austria). There has been no significant reduction in lung cancer-mortality rates in recent years. Chest radiographs can be used to screen for lung cancer. However, these are not always effective and it appears that some cancers are later diagnosed even though individuals have received a negative chest radiograph within the previous 12 months.

The reason for this could be caused by human error with the tumor being missed on the review of the radiograph, due to the cancer being undetectable by this form of screening modality, or because the cancer developed so rapidly that it both initiates and becomes evident in the time interval between screening tests.

Little is known about this form of lung cancer that is not detected by screening chest radiograph, which is referred to as an interval cancer. To improve the understanding of this type of the disease, researchers geared to analyze the type of people who developed this cancer and the characteristics of the disease.

The researchers utilized data from a US screening trial in the United States. It followed 77,445 participants who were screened at the start of the study and then annually for either two or three years depending on their smoking status. A total of 450 people were diagnosed with lung cancer during the years of chest radiograph screening, of which 152 were initially not spotted by the radiograph. Out of this group, 35% of lung cancers not initially identified on the X-ray were spotted when it was re-reviewed. The remaining 65% of this group therefore had “true interval cancer” that was not detected on the initial screening, or the second review.

The study’s findings revealed that these tumors were at a more advanced stage when diagnosed, were more often small-cell lung cancers and less frequently adenocarcinoma. The analysis also demonstrated that this type of cancer was more typical among males and those with a history of smoking.

Lead author, Dr. Paul Kvale, from the Henry Ford Hospital (Detroit, MI, USA), said, “These findings have helped us to understand the characteristics of this type of lung cancer, pointing out features which make them different from lung cancers that can be detected by a chest X-ray screening program. The results add to the evidence that a screening program using X-rays is not suitable for lung cancer, as this this more aggressive form of the disease will be missed. By increasing our understanding of true interval cancers, we can help to improve screening techniques in the future.”

Related Links:
Henry Ford Hospital


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.